Slaoui Aziz, Talib Sarah, Nah Anass, Moussaoui Kamal El, Benzina Intissar, Zeraidi Najia, Baydada Aziz, Kharbach Aicha
Gynaecology-Obstetrics and Endocrinology Department, Maternity Souissi, University Hospital Center IBN SINA, University Mohammed V, Rabat, Morocco.
Gynaecology-Obstetrics and Endoscopy Department, Maternity Souissi, University Hospital Center IBN SINA, University Mohammed V, Rabat, Morocco.
Pan Afr Med J. 2019 Jun 6;33:86. doi: 10.11604/pamj.2019.33.86.17700. eCollection 2019.
Placenta accreta spectrum disorders is a rare pathology but the incidence has not stopped to increase in recent years. The purpose of our work was the analysis of the epidemiological profile of our patients, the circumstances of diagnosis, the interest of paraclinical explorations in antenatal diagnosis and the evaluation of the evolutionary profile. We hereby report a case series spread over a period of one year from 01/01/2015 to 01/01/2016 at the Gynaecology-Obstetrics department of the University Hospital Center IBN SINA of Rabat where we identified six cases of placenta accreta. We selected patients whose diagnosis was confirmed clinically and histologically. The major risk factors identified were a history of placenta previa, previous caesarean section, advanced maternal age, multiparity. 2D ultrasound and magnetic resonance imaging (MRI) allowed us to strongly suspect the presence of a placenta accreta in a pregnant woman with risk factor(s) but the diagnosis of certainty was always histological. Placenta accreta spectrum disorders were associated with a high risk of severe postpartum hemorrhage, serious comorbidities, and maternal death. Leaving the placenta in situ was an option for women who desire to preserve their fertility and agree to continuous long-term monitoring in centers with adequate expertise but a primary elective caesarean hysterectomy was the safest and most practical option. Placenta accreta spectrum disorders is an uncommon pathology that must be systematically sought in a parturient with risk factors, to avoid serious complications. In light of the latest International Federation of Gynecology and Obstetrics (FIGO) recommendations of 2018, a review of the literature and finally the experience of our center, we propose a course of action according to whether the diagnosis of the placenta is antenatal or perpartum.
胎盘植入谱系疾病是一种罕见的病理情况,但近年来其发病率一直在上升。我们这项工作的目的是分析我们患者的流行病学特征、诊断情况、产前诊断中辅助检查的意义以及病情发展情况的评估。在此,我们报告一组病例系列,时间跨度为2015年1月1日至2016年1月1日,来自拉巴特伊本·西那大学医院中心妇产科,我们在那里确诊了6例胎盘植入病例。我们选择了临床和组织学诊断均得到证实的患者。确定的主要危险因素包括前置胎盘病史、既往剖宫产史、高龄产妇、多胎妊娠。二维超声和磁共振成像(MRI)使我们能够强烈怀疑有危险因素的孕妇存在胎盘植入,但确诊始终依靠组织学检查。胎盘植入谱系疾病与严重产后出血、严重合并症及孕产妇死亡的高风险相关。对于希望保留生育能力并同意在有足够专业知识的中心进行长期持续监测的女性,可选择保留胎盘原位,但一期选择性剖宫产子宫切除术是最安全、最实用的选择。胎盘植入谱系疾病是一种罕见的病理情况,对于有危险因素的产妇必须系统排查,以避免严重并发症。根据2018年国际妇产科联合会(FIGO)的最新建议、文献回顾以及我们中心的经验,我们根据胎盘植入的诊断是产前还是产后提出了一套行动方案。